The Global Chemotherapy Induced Anemia Market Size is expected to reach USD 3.99 billion by 2030, at a CAGR of 7.2% during the forecast period 2021 to 2030.Anemia is a common complication of myelosuppressive chemotherapy, and the development of chemotherapy-induced anemia is more common in patients with hematologic malignant tumours.